Gene · 9760
Papers2,030
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,030
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| From exhaustion to functional cure: frontiers in reversing HBV-specific T-cell immunity. | Front Immunol | 2026 | 42519330 | PubTator, text mining | PubMed |
| CD96 marks a phenotypically distinct checkpoint-associated HCV-specific CD8+ T-cell subset featuring memory-associated states. | Front Immunol | 2026 | 42516367 | PubTator, text mining | PubMed |
| Sézary Syndrome Biomarker, T Cell Transcription Factors and Cytokine Genes Provide Novel Insight into Response During Mogamulizumab Treatment. | Cancers (Basel) | 2026 | 42512366 | PubTator, text mining | PubMed |
| Modular delivery of co-stimulatory signals through a PD-1-based immunoswitch receptor improves the functionality of Hepatitis B Virus-specific engineered T cells. | Front Immunol | 2026 | 42491093 | PubTator, text mining | PubMed |
| Hepatic CD8 + TOX + T-cells are a hallmark of autoimmune hepatitis. | bioRxiv | 2026 | 42465294 | PubTator, text mining | PubMed |
| Tumor-driven stabilization of CD8+ T cell exhaustion and implications for cancer immunotherapy. | Front Immunol | 2026 | 42433383 | PubTator, text mining | PubMed |
| Differential stem-like potential of naïve and memory CD8 T cells after chronic infection. | J Immunol | 2026 | 42419960 | PubTator, text mining | PubMed |
| Th2 bias and T-cell exhaustion characterize the immunopathology of non-tuberculous mycobacterial pulmonary disease. | NPJ Syst Biol Appl | 2026 | 42414315 | PubTator, text mining | PubMed |
| Cytotoxic lymphocyte heterogeneity in glioblastoma: insights from single-cell and spatial multiomics toward precision immunotherapeutic reprogramming. | Front Immunol | 2026 | 42358950 | PubTator, text mining | PubMed |
| Shared and context-specific mechanisms of T cell exhaustion in chronic viral infections and cancer: Transcriptional, metabolic, epigenetic, and therapeutic perspectives. | Cytokine Growth Factor Rev | 2026 | 42348970 | PubTator, text mining | PubMed |
| Stem-like precursors of exhausted Th cells upheld by a Tox-Myb-Eomes transcriptional hierarchy propagate Th cell responses in chronic infection. | Immunity | 2026 | 42341754 | PubTator, text mining | PubMed |
| The transcription factor IRF8 drives tumor-specific exhaustion in CD8+ T cells. | J Exp Med | 2026 | 42329236 | PubTator, text mining | PubMed |
| Impact of PD-1+Tim-3+CD8+ T cells in pretreatment tumors on chemotherapy responses in esophageal cancer. | Cancer Immunol Immunother | 2026 | 42313187 | PubTator, text mining | PubMed |
| Simultaneous TCR and IL-2 agonism selectively enhances epitope-specific CD8 T-cell responses during chronic viral infection. | J Virol | 2026 | 42294879 | PubTator, text mining | PubMed |
| Th17-mediated antitumor immunity in patient-derived organoid and autologous immune cell cocultures predicts response to immunotherapy in head and neck cancer. | Immunooncol Technol | 2026 | 42294482 | PubTator, text mining | PubMed |
| CD7 drives CD8 T cell exhaustion during chronic viral infection. | J Immunol | 2026 | 42258808 | PubTator, text mining | PubMed |
| Limited adaptability of virtual memory CD8 T cells to chronic viral infection. | Front Immunol | 2026 | 42254011 | PubTator, text mining | PubMed |
| Defective B cell tolerance in SLE lymph nodes underpins VH4-34 "clonal damnation" and PD-1+TOX+ autoreactive B cells expansion. | medRxiv | 2026 | 42238417 | PubTator, text mining | PubMed |
| T cell exhaustion landscapes and therapeutic modulation in cancer immunity. | Front Cell Dev Biol | 2026 | 42222335 | PubTator, text mining | PubMed |
| Toward a Molecular Reclassification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Integrating Multi-Omics, Machine Learning, and Precision Medicine. | Int J Mol Sci | 2026 | 42196410 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9760/papers?page=2